- Home
- Publications
- Publication Search
- Publication Details
Title
Review: Treatment of
Helicobacter pylori
Infection 2019
Authors
Keywords
-
Journal
HELICOBACTER
Volume 24, Issue S1, Pages -
Publisher
Wiley
Online
2019-09-05
DOI
10.1111/hel.12640
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Favorable outcomes of culture-based Helicobacter pylori eradication therapy in a region with high antimicrobial resistance
- (2019) Jung W. Lee et al. HELICOBACTER
- Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study
- (2019) Antonio Francesco Ciccaglione et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
- (2019) Yoshimasa Saito et al. Cancers
- In Vitro Activity of 3-Bromopyruvate, an Anticancer Compound, Against Antibiotic-Susceptible and Antibiotic-Resistant Helicobacter pylori Strains
- (2019) Paweł Krzyżek et al. Cancers
- Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan
- (2019) Chihiro Kageyama et al. Infection and Drug Resistance
- Effective therapeutic regimens in two South Asian countries with high resistance to major Helicobacter pylori antibiotics
- (2019) Muhammad Miftahussurur et al. Antimicrobial Resistance and Infection Control
- Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real-time PCR
- (2019) Xiao-Yan Zhang et al. Cancer Medicine
- Five alternative Helicobacter pylori antibiotics to counter high levofloxacin and metronidazole resistance in the Dominican Republic
- (2019) Muhammad Miftahussurur et al. PLoS One
- High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment
- (2019) Xue Yang et al. MEDICINE
- Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication
- (2019) Jung Won Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study
- (2019) Young Kwon Choi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial
- (2019) Wei-Chen Tai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cost‐effectiveness analysis and effectiveness of pharmacist‐managed outpatient clinics in Helicobacter pylori eradication therapy
- (2019) Takayuki Seko et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study
- (2019) Tongyu Wang et al. HELICOBACTER
- Bismuth supplements as the first‐line regimen for Helicobacter pylori eradication therapy: Systemic review and meta‐analysis
- (2019) Sung Woo Ko et al. HELICOBACTER
- Meta‐analysis of three‐in‐one single capsule bismuth‐containing quadruple therapy for the eradication of Helicobacter pylori
- (2019) Olga P. Nyssen et al. HELICOBACTER
- Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment
- (2019) Qi Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor
- (2019) Maria Pina Dore et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients
- (2019) Adrian G. McNicholl et al. Clinical Gastroenterology and Hepatology
- Management of Antibiotic-Resistant Helicobacter pylori Infection: Perspectives from Vietnam
- (2019) Vu Van Khien et al. Gut and Liver
- Systematic review: Would susceptibility‐guided treatment achieve acceptable cure rates for second‐line Helicobacter pylori therapy as currently practiced?
- (2019) Mireia Baylina et al. HELICOBACTER
- Efficacy and safety of probiotics in eradicating Helicobacter pylori
- (2019) Xiaoguang Shi et al. MEDICINE
- Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies
- (2019) Orhan Sezgin et al. Turkish Journal of Gastroenterology
- Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients
- (2019) Davide Ribaldone et al. Journal of Clinical Medicine
- Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)
- (2019) Adrian G. McNicholl et al. HELICOBACTER
- Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains
- (2018) L. Gatta et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects
- (2018) J. Sunwoo et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa
- (2018) Patricio Gonzalez-Hormazabal et al. BMC GASTROENTEROLOGY
- Efficacies of different proton pump inhibitor-based 14-day bismuth–furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial
- (2018) Luyi Chen et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial
- (2018) Ping-I Hsu et al. Clinical Gastroenterology and Hepatology
- Primary antibiotic resistance of Helicobacter pylori in Chinese patients: a multiregion prospective 7-year study
- (2018) D.-S. Liu et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pylera and sequential therapy for first-line Helicobacter pylori eradication
- (2018) Giulia Fiorini et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Análisis retrospectivo del uso de la cuádruple terapia con bismuto (Pylera ® ) en la práctica clínica real en España
- (2018) Sandra Agudo-Fernández et al. Gastroenterologia y Hepatologia
- Prevalence of antibiotic resistance in Helicobacter pylori : a systematic review and meta-analysis in World Health Organization regions
- (2018) Alessia Savoldi et al. GASTROENTEROLOGY
- Efficacies of Genotypic Resistance-guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
- (2018) Jyh-Ming Liou et al. GASTROENTEROLOGY
- Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance
- (2018) Xiaohua Long et al. HELICOBACTER
- Systematic review, meta-analysis, and meta-regression: Successful second-line treatment for Helicobacter pylori
- (2018) Neus Muñoz et al. HELICOBACTER
- Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori
- (2018) Min Li et al. HELICOBACTER
- Retrospective study on outcome of salvage Helicobacter pylori eradication therapies based on molecular genetic susceptibility testing
- (2018) Benjamin Blümel et al. HELICOBACTER
- Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria
- (2018) Ping-I Hsu et al. HELICOBACTER
- Helicobacter pylori antibiotic resistance in Portugal: Systematic review and meta-analysis
- (2018) Inês Lopo et al. HELICOBACTER
- The “three-in-one” formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice
- (2018) Rocco Maurizio Zagari et al. HELICOBACTER
- New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial
- (2018) Yong Xie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria
- (2018) Meryem Bachir et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Successful eradication of Helicobacter pylori with a herbal medicine, goshuyuto (Wu Zhu Yu Tang ), plus rabeprazole after failure of triplet therapy with vonoprazan: A report of three cases
- (2018) Yutaka Nagata et al. Journal of Digestive Diseases
- Randomized controlled trial: PPI-based triple therapy containing metronidazole versus clarithromycin as first-line treatment for Helicobacter pylori in adolescents and young adults in Japan
- (2018) Katushiro Mabe et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial
- (2018) Hassan Salmanroghani et al. PLoS One
- Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010–2016
- (2018) Giulia Fiorini et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Key lime (Citrus aurantifolia) inhibits the growth of triple drug resistant Helicobacter pylori
- (2018) Su-Mi Lee et al. Gut Pathogens
- Efficacy of two different dosages of levofloxacin in curing Helicobacter pylori infection: A Prospective, Single-Center, randomized clinical trial
- (2018) Huo-Ye Gan et al. Scientific Reports
- Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
- (2018) Hiroki Tanabe et al. Annals of Clinical Microbiology and Antimicrobials
- Antimicrobial resistance among Helicobacter pylori isolates in Alaska, 2000-2016
- (2018) Emily Mosites et al. Journal of Global Antimicrobial Resistance
- Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
- (2018) Mei-Jyh Chen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial
- (2018) Jean Damascene Kabakambira et al. BMC GASTROENTEROLOGY
- Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial
- (2018) Adrian G. McNicholl et al. HELICOBACTER
- The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus
- (2018) Hsiu-Chi Cheng et al. HELICOBACTER
- Systematic review with network meta-analysis: Effectiveness of therapies for second-line Helicobacter pylori eradication
- (2018) Yee Hui Yeo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori
- (2018) Soichiro Sue et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial
- (2018) Luyi Chen et al. EBioMedicine
- Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial
- (2018) Fernando Macías-García et al. HELICOBACTER
- Optimizing first line 7‐day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better?
- (2018) Alex H.‐R. Leow et al. Journal of Digestive Diseases
- Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
- (2018) Hsiang Tso Huang et al. Infection and Drug Resistance
- Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report
- (2016) P Malfertheiner et al. GUT
- Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults
- (2016) Theresa Wan-Chen Yap et al. PLoS One
- The Effect of Probiotics on Gut Microbiota during theHelicobacter pyloriEradication: Randomized Controlled Trial
- (2015) Bumjo Oh et al. HELICOBACTER
- Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome
- (2010) Hedvig E. Jakobsson et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started